PT  - JOURNAL ARTICLE
AU  - Lisa Kodadek
AU  - Samuel P Carmichael II
AU  - Anupamaa Seshadri
AU  - Abhijit Pathak
AU  - Jason Hoth
AU  - Rachel Appelbaum
AU  - Christopher P Michetti
AU  - Richard P Gonzalez
TI  - Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document
AID  - 10.1136/tsaco-2021-000836
DP  - 2022 Jan 01
TA  - Trauma Surgery & Acute Care Open
PG  - e000836
VI  - 7
IP  - 1
4099  - http://tsaco.bmj.com/content/7/1/e000836.short
4100  - http://tsaco.bmj.com/content/7/1/e000836.full
SO  - Trauma Surg Acute Care Open2022 Jan 01; 7
AB  - Rhabdomyolysis is a clinical condition characterized by destruction of skeletal muscle with release of intracellular contents into the bloodstream. Intracellular contents released include electrolytes, enzymes, and myoglobin, resulting in systemic complications. Muscle necrosis is the common factor for traumatic and non-traumatic rhabdomyolysis. The systemic impact of rhabdomyolysis ranges from asymptomatic elevations in bloodstream muscle enzymes to life-threatening acute kidney injury and electrolyte abnormalities. The purpose of this clinical consensus statement is to review the present-day diagnosis, management, and prognosis of patients who develop rhabdomyolysis.